3 Hot Biotech Penny Stocks to Know About in August
Biotech penny stocks have remained some of the most popular penny stocks to watch throughout the past year and a half. The obvious reason behind this is the impact of the pandemic and the resulting attention on the biotech industry. And while this began as a focus on biotech businesses that were working on pandemic-related compounds or products, it now extends into many facets of the biotech industry.
If you’re looking for a biotech penny stock to buy, there are a few things to keep in mind. In August 2021, it could be beneficial to find companies working on Covid-related treatments. This will help to ensure high volume and promising momentum as the pandemic rolls on.
Another thing to consider is how much funding the company has and how long that funding can sustain it. In the biotech industry, capital is key. Because trials are extremely expensive and can take years, companies need proper funding to keep business operations ongoing. So, while this is not an exhaustive list by any means, it should help to point you in the right direction. With that in mind, let’s take a look at three biotech penny stocks you should know about in August.
3 Biotech Penny Stocks For Your August Watchlist
Outlook Therapeutics Inc. (NASDAQ: OTLK)
Outlook Therapeutics is a biotech penny stock that is seeing solid bullish momentum right now. The company’s primary focus is on creating monoclonal antibodies. One of its lead products is ONS-5010 which is in Phase 3 trial to treat various retina diseases. The company also has active agreements with IPCA Laboratories Limited and other biotech companies to improve its operations. Because of its broad scope, Outlook Therapeutics looks like a well-positioned biotech penny stock to watch.
On August 3rd, Outlook reported positive efficacy and safety data from its Phase 3 NORSE TWO ONS-5010 trial, which is also known as LYTENAVA. The trial achieved “statistically significant and clinically relevant” efficacy endpoints.
The company’s President and CEO, C. Russell Trenary III said, “The successful completion of this trial is the final step needed in our clinical evaluation of ONS-5010 to enable us to submit a Biologics License Application to the FDA in the first calendar quarter of next year.”
With positive safety and efficacy data from this trial, Outlook could move forward with this compound in the near future. And, this is likely the reason that shares of OTLK had at one point on August 3rd, shot up by over 30%. This recent advancement has caused Outlook Therapeutics to increase significantly in the stock market. OTLK stock is up 8% on the day of August 3rd. With this information in mind, is OTLK a contender for your list of penny stocks to watch?
Lixte Biotechnology Holdings Inc. (NASDAQ: LIXT)
Another biotech penny stock that is performing well right now Lixte Biotechnology Holdings Inc. Lixte creates drugs targeted at treating serious and common diseases. Currently, the company develops two series of pharmaceutical drugs; LB-200 and LB-100. The LB-200 series is for treating chronic hereditary diseases such as cancer. Its LB-100 series is for treating vascular and metabolic diseases, as well as different types of cancer. On August 3rd, a preclinical study reported that Lixte’s LB-100 potentiates standard therapy for small cell lung cancer.
“LB-100 has been reported to increase the effectiveness of a number of anti-cancer drugs against several different types of human cancers without increasing toxicity in animal models. Of note in the current preclinical study of SCLC cells is 1) that LB-100 increases the amount of carboplatin that enters the tumor cells without increasing toxicity, and 2) that LB-100 potentiates the action of the immune-blocker, atezolizumab.”
The CEO of Lixte, John S. Kovach
Following this announcement, LIXT stock experienced a very large spike. Currently, LIXT volume is more than 83 times its market average. This is a solid sign of popularity with LIXT stock and a reaction to this news. With this in mind, is LIXT going to make your penny stock watchlist?
iBio Inc. (NYSE: IBIO)
Shares of IBIO stock have seen a great deal of investor attention over the past few weeks. This company provides biotech-related contract development services to various companies in the U.S. In addition to contract development, iBio also provides manufacturing services for large biotech firms as well. Also of note is that iBio is in the development of several drug candidates at the moment. Two of these drug candidates are IBIO-200 and IBIO-201, which are in preclinical development for respiratory syndrome related to COVID-19.
One thing to keep in mind is that biotech companies with positive contributions to the pandemic can see increases in popularity. This makes sense with the pandemic still ongoing, and the increased need for new drugs to treat Covid-19. On July 15th, iBio reported successful preclinical immunization studies with its IBIO-202 subunit vaccine candidate.
“Studies of convalescent sera from patients that have recovered from SARS-CoV-2 infection have shown that the combination of N-directed and S-directed immunity is important. Accordingly, we believe the N protein strategy of IBIO-202 may be complementary with existing S-directed vaccines, conferring additional protective effects that more closely mimic the natural immune responses of patients that have cleared the virus.”
of iBio Inc., Martin Brenner
While there are several vaccine candidates on the market and a select few that have gotten EUA authorization, there is always room for more. This is especially true when we consider the effects of the Delta variant and the recent uptick in case numbers globally. So, with this new advancement in mind, is IBIO a contender for your penny stock watchlist?
Which Biotech Penny Stocks Are You Watching Right Now?
With a major focus on biotech penny stocks right now, there is plenty of opportunity to be had. But, it all comes down to knowing where to look and how to find the best penny stocks to buy regardless of the industry.
And in 2021, there are plenty of factors that are aiding in the volatility we see in the stock market right now. This leaves a lot of room for potential profits and intraday moves. With all of this in mind, which biotech penny stocks are you watching right now?